| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.39B | +253.8% |
| Gross profit | ¥0.02B | — |
| Operating income | ¥-0.00B | — |
| Net income | ¥0.01B | +1.5% |
| Gross margin | 5.7% | Net margin 1.4% |
| Revenue Q/Q | +17.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.37B | 94.3% |
| R&D | ¥0.00B | 0.5% |
| SG&A | ¥0.02B | 5.6% |
| Tax & other | ¥-0.01B | -1.8% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
北陆药业 ・ 网宿科技 ・ 中元股份 ・ 硅宝科技 ・ ST银江 ・ 大禹节水 ・ 吉峰科技 ・ 机器人 ・ 华星创业 ・ 红日药业 ・ ST华谊 ・ 阳普医疗
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies